Tobacco Center Faculty Blog

June 25, 2024

Several people have asked us to collect all the public comments that we have submitted to the FDA.  We have also added comments submitted to other agencies on tobacco issues.  We will update this posting as new comments are submitted.  This post is current as of June 25, 2024.

Swedish Match Snus 2024 MRTP Renewal Applicaton

FDA should not renew the Modified Risk Granted Order for eight Swedish Match General Snus modified risk tobacco product application for General Snus

FDA should consider the significant public health issues, especially for youth, created by PMI’s co-marketing of its Swedish Match General Snus products with its Swedish Match ZYN oral nicotine products

Developing FDA’s Center for Tobacco Products’ Strategic Plan

January 31, 2024

Greetings and Happy New Year everyone!

We are very happy to announce a partnership between the University of North Carolina at Chapel Hill University Libraries and the University of California, San Francisco (UCSF) resulting in a new acquisition of roughly 4 million internal documents from the State of North Carolina’s $40 million settlement with electronic cigarette maker JUUL Labs:

The first 280,000 documents are now available online as part of the UCSF Truth Tobacco Industry Documents and we plan to publish the remaining documents monthly, concluding the project in 2025.

See the UNC announcement for more information on the partnership:



December 19, 2023

Jelena Mustra Rakic, PhD

African Americans face a higher stroke risk than other racial groups in the U.S., which is not fully accounted for by traditional risk factors or socioeconomic differences. Tobacco smoking, a well-established independent risk factor for stroke and responsible for one-fifth of all strokes in the US, has only recently been evaluated in this population. The 2.5 times higher risk for African American smokers compared to non-smokers, is even greater when contrasted with non-Hispanic Whites, highlighting the need to investigate the underlying reasons for this disparity.

August 29, 2023

On Friday, August 25, 2023 UCSF TCORS submitted six public comments following the FDA’s Public Meeting and Listening Session for Developing their Center for Tobacco Products' Strategic Plan.

August 3, 2023

HHS’s proposed Framework to Support and Accelerate Smoking Cessation is an important first step to addressing health disparities among populations disproportionately impacted by smoking-related illness and death. In particular, the framework focuses on closing the gap in culturally tailored cessation treatments and programs available, improving accessibility to these disproportionately impacted populations, and acknowledging the importance of policies and programs at the population level that will support an individual’s successful attempts to quit smoking. While we generally support the proposed framework’s goals, cross-cutting principles, and broad strategies, we offer some suggestions to strengthen the framework and increase impact on preventing cancer deaths and other smoking-caused deaths.